by Temple University Credit: Unsplash/CC0 Public Domain Medicines that are based on mRNAs and proteins—particularly vaccines and antibodies—are time-intensive and costly to make. The challenge is in producing the necessary mRNAs and proteins in large enough amounts at low cost. Now, researchers at the Lewis Katz School of Medicine at Temple University have discovered a new way...
